8th Circ. Panel Doubts Investors' Medtronic Insulin Pump Suit
The Eighth Circuit appeared skeptical Tuesday of investors' bid to revive allegations that medical device company Medtronic failed to properly communicate problems with an insulin pump device it manufactured and was ultimately...To view the full article, register now.
Already a subscriber? Click here to view full article